Physician profile
Matthew Mclean
NPI 1669571758
$803.63
in general payments reported to CMS, 2019-2025
13 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $91.07 · 2021: $31.94 · 2022: $28.63 · 2023: $159 · 2024: $228 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $651.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $305.24 | 2022-2025 | Gel-One Cross-Linked Hyaluronate, Tricera Handpiece, Stratum Foot Plating System |
| Depuy Synthes Sales INC. | $169.02 | 2021-2025 | Va-Lcp |
| Allergan, INC. | $73.52 | 2020 | |
| Stryker Corporation | $66.26 | 2023 | Na |
| Biocomposites INC | $48.57 | 2025 | Stimulan |
| Life Molecular Imaging LTD | $21.97 | 2024 | Neuraceq |
| Radius Health, INC. | $21.83 | 2024 | Tymlos |
| Bioventus LLC | $18.01 | 2024 | Durolane |
| Biogen, INC. | $17.55 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $17.00 | 2025 | |
| Ferring Pharmaceuticals INC. | $16.31 | 2024 | Euflexxa |
| Abbvie INC. | $14.65 | 2023 | |
| Janssen Pharmaceuticals, INC | $13.70 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Mclean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.